Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,404 GBX | +0.47% | +3.13% | +17.02% |
Jun. 04 | Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete | MT |
Jun. 04 | ASTRAZENECA : UBS reiterates advice after ASCO meeting | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.02% | 245B | |
+42.83% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+18.06% | 325B | |
+4.63% | 283B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.43% | 166B | |
+6.67% | 165B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Discontinues Two Phase 3 Evidence Trials of Lokelma in Managing Hyperkalemia